WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007005244) HENIPAVIRUS RECEPTOR AND USES THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/005244    International Application No.:    PCT/US2006/023618
Publication Date: 11.01.2007 International Filing Date: 16.06.2006
IPC:
C07K 14/115 (2006.01), C07K 14/715 (2006.01), A61K 38/17 (2006.01), A61K 39/155 (2006.01), G01N 33/50 (2006.01)
Applicants: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA [US/US]; Office of Technology Transfer, Office of the President, 1111 Franklin Street, 5th Floor, Oakland, CA 94607-5200 (US) (For All Designated States Except US).
LEE, Benhur [SG/US]; (US) (For US Only).
NEGRETE, Oscar, A. [US/US]; (US) (For US Only)
Inventors: LEE, Benhur; (US).
NEGRETE, Oscar, A.; (US)
Agent: MILLER, Elizabeth, Cary; Morrison & Foerster LLP, 12531 High Bluff Drive, Suite 100, San Diego, CA 92130-2040 (US)
Priority Data:
60/696,972 05.07.2005 US
Title (EN) HENIPAVIRUS RECEPTOR AND USES THEREOF
(FR) RECEPTEUR DE L'HENIPAVIRUS ET SES UTILISATIONS
Abstract: front page image
(EN)The present invention provides compositions and methods of preventing or treating viruses in the Henipavirus genus. The Henipavirus can be a Nipah (NiV) virus or a Hendra (HeV) virus. In particular, the invention provides inhibitors and modulators of NiV viral attachment to the cell through interaction of the Hendravirus attachment (G) glycoprotein with EphrinB2 or EphrinB3.
(FR)L'invention porte sur des compositions et procédés de prévention ou traitement de virus du genre Hénipavirus. Il peut s'agir du virus Nipah (NiV) ou du virus Hendra (HeV). L'invention porte en particulier sur des inhibiteurs et des modulateurs de la fixation virale du NiV à la cellule par l'intermédiaire de l'interaction de la glycoprotéine (G) de fixation de l'Hendravirus avec l'EphrineB2 ou l'EphrineB3.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)